Cargando…
Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy
Livedoid vasculopathy (LV) is a rare clinical condition presenting as painful lesions mostly on the lower extremities. We present a case of LV with peripheral neuropathy in a young man initially misdiagnosed and treated for cellulitis. He was started on aspirin, pentoxifylline and apixaban immediate...
Autores principales: | , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
SMC Media Srl
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930874/ https://www.ncbi.nlm.nih.gov/pubmed/36819654 http://dx.doi.org/10.12890/2023_003727 |
_version_ | 1784889123208691712 |
---|---|
author | Palanisamy, Nageshwari Chinnappan, Justine Bachuwa, Ghassan |
author_facet | Palanisamy, Nageshwari Chinnappan, Justine Bachuwa, Ghassan |
author_sort | Palanisamy, Nageshwari |
collection | PubMed |
description | Livedoid vasculopathy (LV) is a rare clinical condition presenting as painful lesions mostly on the lower extremities. We present a case of LV with peripheral neuropathy in a young man initially misdiagnosed and treated for cellulitis. He was started on aspirin, pentoxifylline and apixaban immediately after the diagnosis of LV. However, pain management was a real challenge for the clinicians. Hence, he was later treated with epoprostenol and amlodipine for vasodilation, steroids for any possible inflammation, and antibiotics to treat superimposed infection. Irrespective of all the above, his pain was uncontrollable, and he finally received ketamine infusions along with narcotics, achieving better pain control. Various studies support the use of intravenous immunoglobulin and anti-TNF agents for pain relief in idiopathic and secondary LV. Intermittent low-dose dabigatran has also been found to be effective in the maintenance of remission in LV. However, no large studies have yet been conducted to confirm the efficacy of these medications. LEARNING POINTS: Early initiation of treatment with antiplatelets and anticoagulants is recommended to prevent the progression of livedoid vasculopathy (LV). Anti-TNF agents can be tried in refractory LV for rapid relief of pain. Intravenous immunoglobulin has been shown to be effective for the resolution of pain and improvement of neuropathic symptoms especially in LV refractory to immunosuppressive agents. |
format | Online Article Text |
id | pubmed-9930874 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | SMC Media Srl |
record_format | MEDLINE/PubMed |
spelling | pubmed-99308742023-02-16 Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy Palanisamy, Nageshwari Chinnappan, Justine Bachuwa, Ghassan Eur J Case Rep Intern Med Article Livedoid vasculopathy (LV) is a rare clinical condition presenting as painful lesions mostly on the lower extremities. We present a case of LV with peripheral neuropathy in a young man initially misdiagnosed and treated for cellulitis. He was started on aspirin, pentoxifylline and apixaban immediately after the diagnosis of LV. However, pain management was a real challenge for the clinicians. Hence, he was later treated with epoprostenol and amlodipine for vasodilation, steroids for any possible inflammation, and antibiotics to treat superimposed infection. Irrespective of all the above, his pain was uncontrollable, and he finally received ketamine infusions along with narcotics, achieving better pain control. Various studies support the use of intravenous immunoglobulin and anti-TNF agents for pain relief in idiopathic and secondary LV. Intermittent low-dose dabigatran has also been found to be effective in the maintenance of remission in LV. However, no large studies have yet been conducted to confirm the efficacy of these medications. LEARNING POINTS: Early initiation of treatment with antiplatelets and anticoagulants is recommended to prevent the progression of livedoid vasculopathy (LV). Anti-TNF agents can be tried in refractory LV for rapid relief of pain. Intravenous immunoglobulin has been shown to be effective for the resolution of pain and improvement of neuropathic symptoms especially in LV refractory to immunosuppressive agents. SMC Media Srl 2023-01-30 /pmc/articles/PMC9930874/ /pubmed/36819654 http://dx.doi.org/10.12890/2023_003727 Text en © EFIM 2023 https://creativecommons.org/licenses/by-nc-nd/4.0/This article is licensed under a Commons Attribution Non-Commercial 4.0 License (https://creativecommons.org/licenses/by-nc-nd/4.0/) |
spellingShingle | Article Palanisamy, Nageshwari Chinnappan, Justine Bachuwa, Ghassan Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy |
title | Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy |
title_full | Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy |
title_fullStr | Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy |
title_full_unstemmed | Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy |
title_short | Pain Management Options in a Patient with Livedoid Vasculopathy and Peripheral Neuropathy |
title_sort | pain management options in a patient with livedoid vasculopathy and peripheral neuropathy |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9930874/ https://www.ncbi.nlm.nih.gov/pubmed/36819654 http://dx.doi.org/10.12890/2023_003727 |
work_keys_str_mv | AT palanisamynageshwari painmanagementoptionsinapatientwithlivedoidvasculopathyandperipheralneuropathy AT chinnappanjustine painmanagementoptionsinapatientwithlivedoidvasculopathyandperipheralneuropathy AT bachuwaghassan painmanagementoptionsinapatientwithlivedoidvasculopathyandperipheralneuropathy |